Dolman CD - Search Results

1

Batches of intravenous immunoglobulin associated with adverse reactions in recipients contain atypically high anti-Rh D activity.

Thorpe SJ, Fox BJ, Dolman CD, Lawrence J, Thorpe R. Thorpe SJ, et al. Among authors: dolman cd. Vox Sang. 2003 Aug;85(2):80-4. doi: 10.1046/j.1423-0410.2003.00336.x. Vox Sang. 2003. PMID: 12925158

2

Anti-A and anti-B activity in batches of different intravenous immunoglobulin products determined using a direct haemagglutination method.

Thorpe SJ, Fox BJ, Dolman CD, Thorpe R. Thorpe SJ, et al. Among authors: dolman cd. Biologicals. 2005 Jun;33(2):111-6. doi: 10.1016/j.biologicals.2005.02.002. Biologicals. 2005. PMID: 15905100

3

Enhanced efficacy of anti-D immunoglobulin for treating ITP is not explained by higher immunoglobulin polymer content.

Dolman C, Thorpe SJ, Thorpe R. Dolman C, et al. Biologicals. 2001 Jun;29(2):75-9. doi: 10.1006/biol.2001.0279. Biologicals. 2001. PMID: 11580212

4

International collaborative study to evaluate a candidate reference preparation to define an appropriate specified limit of anti-D in intravenous immunoglobulin products.

Thorpe SJ, Fox B, Heath A, Dolman C, Virata ML, Yu MW, Thorpe R. Thorpe SJ, et al. Vox Sang. 2005 May;88(4):278-87. doi: 10.1111/j.1423-0410.2005.00622.x. Vox Sang. 2005. PMID: 15877651

5

"Cytokine storm" in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeutics.

Stebbings R, Findlay L, Edwards C, Eastwood D, Bird C, North D, Mistry Y, Dilger P, Liefooghe E, Cludts I, Fox B, Tarrant G, Robinson J, Meager T, Dolman C, Thorpe SJ, Bristow A, Wadhwa M, Thorpe R, Poole S. Stebbings R, et al. J Immunol. 2007 Sep 1;179(5):3325-31. doi: 10.4049/jimmunol.179.5.3325. J Immunol. 2007. PMID: 17709549

6

Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations.

Wadhwa M, Meager A, Dilger P, Bird C, Dolman C, Das RG, Thorpe R. Wadhwa M, et al. Immunology. 2000 Jan;99(1):113-23. doi: 10.1046/j.1365-2567.2000.00949.x. Immunology. 2000. PMID: 10651949 Free PMC article.

7

Characterization of complete particles (VSV-G/SIN-GFP) and empty particles (VSV-G/EMPTY) in human immunodeficiency virus type 1-based lentiviral products for gene therapy: potential applications for improvement of product quality and safety.

Zhao Y, Keating K, Dolman C, Thorpe R. Zhao Y, et al. Hum Gene Ther. 2008 May;19(5):475-86. doi: 10.1089/hum.2007.119. Hum Gene Ther. 2008. PMID: 18412516

8

A WHO Reference Reagent for lupus (anti-dsDNA) antibodies: international collaborative study to evaluate a candidate preparation.

Fox BJ, Hockley J, Rigsby P, Dolman C, Meroni PL, Rönnelid J. Fox BJ, et al. Ann Rheum Dis. 2019 Dec;78(12):1677-1680. doi: 10.1136/annrheumdis-2019-215845. Epub 2019 Sep 5. Ann Rheum Dis. 2019. PMID: 31488407 Free PMC article.

9

An assessment of biological potency and molecular characteristics of different innovator and noninnovator interferon-beta products.

Meager A, Dolman C, Dilger P, Bird C, Giovannoni G, Schellekens H, Thorpe R, Wadhwa M. Meager A, et al. J Interferon Cytokine Res. 2011 Apr;31(4):383-92. doi: 10.1089/jir.2010.0113. Epub 2010 Dec 7. J Interferon Cytokine Res. 2011. PMID: 21138379

10

Adherence of Older Cardiac Patients to a Home-Based Cardiac Rehabilitation Program.

van Erck D, Terbraak M, Dolman CD, Weijs PJM, Henriques JP, Delewi R, Verweij L, Jepma P, Scholte Op Reimer WJM, Schoufour JD. van Erck D, et al. Among authors: dolman cd. Geriatrics (Basel). 2023 May 13;8(3):53. doi: 10.3390/geriatrics8030053. Geriatrics (Basel). 2023. PMID: 37218833 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page